Prognostic Value of EGFR Expression for Patients With Stage III Colorectal Cancer Receiving Fluoropyrimidine Metronomic Maintenance Therapy After Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy

This study evaluated the survival effects of metronomic maintenance therapy with oral fluoropyrimidine in patients with stage III colorectal cancer (CRC) according to epidermal growth factor receptor (EGFR) expression. We enrolled 197 patients with stage III CRC who had undergone radical resection a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ching-Wen, Ma, Cheng-Jen, Su, Wei-Chih, Chen_, Yi-Ting, Tsai, Hsiang-Lin, Yeh, Yung-Sung, Chang, Tsung-Kun, Hsu, Wen-Hung, Yu, Fang-Jung, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420899/
https://www.ncbi.nlm.nih.gov/pubmed/32859280
http://dx.doi.org/10.3727/096504020X15986099915822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420899/
https://www.ncbi.nlm.nih.gov/pubmed/32859280
http://dx.doi.org/10.3727/096504020X15986099915822

Ejemplares similares